Bank of America’s ONCOLYTICS BIOTECH INC ONCY Stock Holding History

Bank of America’s Portfolio ONCY Stock Details ONCY Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2015 Q4	–	Sell	-11,944	Closed	-$5K	–	7709
2015 Q3	$5K	Buy	11,944 +4,844	+68%	+$2.77K	﹤0.01%	6792
2015 Q2	$3K	Sell	7,100 -10,500	-60%	-$7.13K	﹤0.01%	7013
2015 Q1	$13K	Buy	17,600 +10,500	+148%	+$6.74K	﹤0.01%	6231
2014 Q4	$3K	Buy	7,100 +2,000	+39%	+$1.21K	﹤0.01%	7451
2014 Q3	$3K	Sell	5,100 -2,200	-30%	-$2.79K	﹤0.01%	7731
2014 Q2	$10K	Buy	7,300 +100	+1%	+$143	﹤0.01%	7480
2014 Q1	$13K	Buy	7,200 +500	+7%	+$844	﹤0.01%	7114
2013 Q4	$11K	Buy	6,700 +2,100	+46%	+$4.73K	﹤0.01%	7270
2013 Q3	$11K	Sell	4,600 -100	-2%	-$277	﹤0.01%	7155
2013 Q2	$14K	Buy	+4,700	New	+$13K	﹤0.01%	7086

Other funds holding ONCY

NFG

Next Financial Group Houston, Texas $1.52B AUM 20.14% 1-Year Est. Return

KWMG

King Wealth Management Group Naples, Florida $914M AUM 24.3% 1-Year Est. Return

Credential Securities Vancouver $440M AUM 9.75% 1-Year Est. Return

Bank of America's ONCY Position: Q4 2015 in Review

Bank of America sold out of ONCOLYTICS BIOTECH INC (ONCY) in Q4 2015, closing a stake of 11,944 shares — an estimated $5K sold.

Bank of America first reported a position in ONCY in Q2 2013 and held it in 10 quarters. The position peaked at $14K in Q2 2013. 7 funds tracked by Wall St. Rank hold ONCY as of Q4 2015.

Bank of America reported no remaining ONCOLYTICS BIOTECH INC position as of Q4 2015 after selling out during the quarter.
Bank of America sold 11,944 ONCOLYTICS BIOTECH INC shares in Q4 2015, an estimated $5K.
Bank of America first reported a position in ONCOLYTICS BIOTECH INC in Q2 2013 and held it in 10 quarters.
Bank of America's ONCOLYTICS BIOTECH INC position peaked at $14K in Q2 2013.
7 funds tracked by Wall St. Rank held ONCOLYTICS BIOTECH INC as of Q4 2015.

Based on Bank of America's 13F filing for Q4 2015, filed 16 Feb 2016.